You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Richter's transformation

Showing 1 - 25 of 491
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Richter Syndrome, Chronic Lymphocytic Leukemia Trial in New York (Polatuzumab Vedotin, Rituximab, Etoposide)

Recruiting
  • Richter Syndrome
  • Chronic Lymphocytic Leukemia
  • Polatuzumab Vedotin
  • +5 more
  • New York, New York
    Weill Cornell Medicine
Dec 19, 2022

Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)

Completed
  • Hematopoietic/Lymphoid Cancer
  • Richter's Transformation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Germany (Obinutuzumab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Obinutuzumab
  • Bonn, Germany
  • +6 more
Dec 16, 2021

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 10, 2022

    Richter Transformation Trial in Austria, Denmark, Germany (Tislelizumab, Zanubrutinib)

    Recruiting
    • Richter Transformation
    • Vienna, Austria
    • +11 more
    Mar 8, 2022

    Chronic Lymphocytic Leukemia, DLBCL, Follicular Lymphoma Trial in Duarte, Boston, Portland (Copanlisib, Nivolumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +2 more
    Mar 9, 2022

    CLL Transformation Trial in Italy, Switzerland (Obinutuzumab 25 MG/ML [Gazyva], Atezolizumab 60 MG/ML [Tecentriq], Venetoclax

    Recruiting
    • CLL Transformation
    • Obinutuzumab 25 MG/ML [Gazyva]
    • +2 more
    • Alessandria, Italy
    • +16 more
    Sep 27, 2022

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +2 more
    • Biopsy
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

    Not yet recruiting
    • Relapsed/Refractory Waldenstrom Macroglobulinemia
    • +3 more
    • Brexucabtagene Autoleucel
    • +2 more
    • (no location specified)
    Sep 8, 2022

    Chronic Lymphocytic Leukemia, CLL/SLL Trial in New York (Acalabrutinib)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • CLL/SLL
    • New York, New York
      Weill Cornell Medicine
    Mar 25, 2022

    Richter Syndrome Trial in France (RCHOP, Blinatumomab)

    Active, not recruiting
    • Richter Syndrome
    • Amiens, France
    • +27 more
    Jul 26, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spokane, Salamanca (Zilovertamab vedotin,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Spokane, Washington
    • +1 more
    Aug 12, 2022

    Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Completed
    • Loss of Chromosome 17p
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    Jan 20, 2023

    Richter Transformation Trial in China (R-EPOCH in Combination With Ibrutinib)

    Not yet recruiting
    • Richter Transformation
    • R-EPOCH in Combination With Ibrutinib
    • Beijing, Beijing, China
    • +10 more
    Jul 29, 2021

    B-cell Non Hodgkin Lymphoma, Richter's Transformation Trial in United States (Cosibelimab, Cosibelimab + Ublituximab +

    Terminated
    • B-cell Non Hodgkin Lymphoma
    • Richter's Transformation
    • Cosibelimab
    • Cosibelimab + Ublituximab + Bendamustine combination
    • Huntsville, Alabama
    • +8 more
    Aug 19, 2022

    Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021

    Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

    Recruiting
    • Ovarian Cancer, Epithelial
    • +14 more
    • Sutton, Surrey, United Kingdom
    • +6 more
    Jul 22, 2022

    Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma Trial in United

    Recruiting
    • Relapsed Chronic Lymphocytic Leukemia
    • +4 more
    • Phoenix, Arizona
    • +7 more
    Apr 28, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Richter's Transformation Trial in Worldwide (selinexor)

    Terminated
    Has Results
    • Richter's Transformation
    • Tucson, Arizona
    • +16 more
    Sep 8, 2020